These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 17320937)
41. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study. Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565 [TBL] [Abstract][Full Text] [Related]
42. Conservative management of a myxoid endometrial stromal sarcoma in a 16-year-old nulliparous woman. Stadsvold JL; Molpus KL; Baker JJ; Michael K; Remmenga SW Gynecol Oncol; 2005 Oct; 99(1):243-5. PubMed ID: 16054205 [TBL] [Abstract][Full Text] [Related]
43. The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study. Dahhan T; Fons G; Buist MR; Ten Kate FJ; van der Velden J Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):80-4. PubMed ID: 19269732 [TBL] [Abstract][Full Text] [Related]
44. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications. Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168 [TBL] [Abstract][Full Text] [Related]
45. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852 [TBL] [Abstract][Full Text] [Related]
46. Tumor volume as a prognostic factor for sarcomatosis. Bilimoria MM; Holtz DJ; Mirza NQ; Feig BW; Pisters PW; Patel S; Pollock RE; Benjamin RS; Papadopoulos NE; Plager C; Murphy A; Griffin JR; Burgess MA; Hunt KK Cancer; 2002 May; 94(9):2441-6. PubMed ID: 12015769 [TBL] [Abstract][Full Text] [Related]
48. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263 [TBL] [Abstract][Full Text] [Related]
49. Interphase cytogenetic study of endometrial stromal sarcoma by chromosome in situ hybridization. Cheung AN; Tin VP; Ngan HY; Chung LP; Khoo US Mod Pathol; 1996 Sep; 9(9):910-8. PubMed ID: 8878023 [TBL] [Abstract][Full Text] [Related]
50. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Ramondetta LM; Johnson AJ; Sun CC; Atkinson N; Smith JA; Jung MS; Broaddus R; Iyer RB; Burke T Cancer; 2009 May; 115(9):1867-74. PubMed ID: 19241422 [TBL] [Abstract][Full Text] [Related]
51. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214 [TBL] [Abstract][Full Text] [Related]
52. The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients. Quan C; Zheng Z; Cao S; Wu Y; Zhang W; Huang Y J Gynecol Oncol; 2024 Jul; 35(4):e98. PubMed ID: 38725236 [TBL] [Abstract][Full Text] [Related]
53. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups. Bartosch C; Exposito MI; Lopes JM Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859 [TBL] [Abstract][Full Text] [Related]
54. Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer. Boardman CH; Webb MJ; Jefferies JA Gynecol Oncol; 2000 Oct; 79(1):120-3. PubMed ID: 11006043 [TBL] [Abstract][Full Text] [Related]